Human defensin-inspired discovery of peptidomimetic antibiotics
SignificanceWe report the development of peptidomimetic antibiotics derived from a natural antimicrobial peptide, human α-defensin 5. By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
---|---|
Enthalten in: |
Proceedings of the National Academy of Sciences of the United States of America - 119(2022), 10 vom: 08. März, Seite e2117283119 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Luo, Gan [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 21.03.2022 Date Revised 02.09.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1073/pnas.2117283119 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM337699208 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM337699208 | ||
003 | DE-627 | ||
005 | 20231225235016.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1073/pnas.2117283119 |2 doi | |
028 | 5 | 2 | |a pubmed24n1125.xml |
035 | |a (DE-627)NLM337699208 | ||
035 | |a (NLM)35238683 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Luo, Gan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Human defensin-inspired discovery of peptidomimetic antibiotics |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.03.2022 | ||
500 | |a Date Revised 02.09.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a SignificanceWe report the development of peptidomimetic antibiotics derived from a natural antimicrobial peptide, human α-defensin 5. By engaging multiple bacterial targets, the lead compound is efficacious in vitro and in vivo against bacteria with highly inducible antibiotic resistance, promising a useful therapeutic agent for the treatment of infections caused by antibiotic-resistant bacteria | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a antimicrobial resistance | |
650 | 4 | |a defensins | |
650 | 4 | |a infections | |
650 | 4 | |a peptidomimetic antibiotics | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Defensins |2 NLM | |
650 | 7 | |a Peptidomimetics |2 NLM | |
700 | 1 | |a Zhang, Jue |e verfasserin |4 aut | |
700 | 1 | |a Wang, HanBin |e verfasserin |4 aut | |
700 | 1 | |a Sun, YaQi |e verfasserin |4 aut | |
700 | 1 | |a Cheng, BaoLi |e verfasserin |4 aut | |
700 | 1 | |a Xu, ZhiPeng |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Li, Hui |e verfasserin |4 aut | |
700 | 1 | |a Lu, WuYuan |e verfasserin |4 aut | |
700 | 1 | |a Nemeth, Elizabeta |e verfasserin |4 aut | |
700 | 1 | |a Ganz, Tomas |e verfasserin |4 aut | |
700 | 1 | |a Fang, XiangMing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Proceedings of the National Academy of Sciences of the United States of America |d 1915 |g 119(2022), 10 vom: 08. März, Seite e2117283119 |w (DE-627)NLM000008982 |x 1091-6490 |7 nnns |
773 | 1 | 8 | |g volume:119 |g year:2022 |g number:10 |g day:08 |g month:03 |g pages:e2117283119 |
856 | 4 | 0 | |u http://dx.doi.org/10.1073/pnas.2117283119 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 119 |j 2022 |e 10 |b 08 |c 03 |h e2117283119 |